The relationship between Müllerian inhibiting substance and androgens in boys with hypospadias

Journal of Urology

Volumn 168, Issue 4 II, 2002, Pages 1784-1788

  Austin, Paul F ^a   Siow, Yong ^a   Fallat, Mary E ^a   Cain, Mark P ^a   Rink, Richard C ^a   Casale, Anthony J ^a   Aaronson, Ian ^a   Khoury, Antoine ^a   Zderic, Steve ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Hypospadias; M llerian Ducts; Testosterone

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CYTOCHROME P450C17; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; BIOSYNTHESIS; BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; GENE EXPRESSION; HUMAN; HYPOSPADIAS; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SERTOLI CELL; STANDARD; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL;

EID: 0036784261     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200210020-00031     Document Type: Conference Paper

References (33)

1. The biochemical role of SRY in sex determination
2. Mullerian-inhibiting substance: An update
3. Testosterone formation and metabolism during male sexual differentiation in the human embryo
4. Testosterone and dihydrotestosterone in sexual ducts and genital tubercle of rabbit fetuses during sexual organogenesis: Effects of fetal decapitation
5. The endocrine control of male phenotypic development
6. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: Dose-response studies
7. Dihydrotestosterone formation in fetal tissues of the rabbit and rat
8. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias
9. Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias
10. Sex-specific fetal lung development and mullerian inhibiting substance
11. Historical review of theories on testicular descent
12. Mullerian-inhibiting substance regulates androgen synthesis at the transcriptional level
13. The presence of mullerian inhibiting substance in human seminal plasma
14. Characterization of the testicular abnormality in 5 alpha-reductase deficiency
15. Anti-mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development
16. Mullerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications
17. Anti-mullerian hormone in early human development
18. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood
19. The syndromes of androgen resistance
20. Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells
21. Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian hormone expression in transgenic mice
22. Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance
23. Mullerian-inhibiting substance function during mammalian sexual development
24. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation
25. Mullerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells
26. Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats
27. Mullerian inhibiting substance inhibits testosterone synthesis in adult rats
28. Serum levels of mullerian inhibiting substance in preterm and term male neonates
29. Management of mullerian duct remnants in the male patient
30. Remnants of the Mullerian duct. Case report based on a complex urogenital abnormality
31. Molecular genetics of the persistent mullerian duct syndrome: A study of 19 families
32. Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor